EMAIL THIS PAGE TO A FRIEND

Texas Heart Institute journal

Ergotamine-associated valvulopathy with recurrent chylous pleural effusion.


PMID 23109782

Abstract

We report a rare case of ergotamine-associated mitral stenosis in a 55-year-old woman who presented with recurrent chylous pleural effusion. Echocardiographic, gross, and microscopic features of the mitral valve were consistent with chronic ergotamine-induced valvulopathy. We conclude that medication-induced valvulopathy should be included in the differential diagnosis of valvular heart disease. In addition, cardiac function should be monitored before and during long-term therapy with ergotamine or ergotamine-derived dopamine agonists.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

45510
Ergotamine D-tartrate, ≥97.0% (calc. based on dry substance, NT)
C33H35N5O5 · 0.5C4H6O6